The trial will enrol around 40 advanced melanoma patients at up to 18 clinical sites in the UK, Italy, France and Spain. Credit: Evgeniy Kalinovskiy/Shutterstock ...
The trial aims to enrol 87 subjects with low-grade intermediate-risk non-muscle invasive bladder cancer. Credit: Antonio Marca/Shutterstock. UroGen Pharma has announced the dosing of the first subject ...